Osteopontin
Aliases:
This biomarker is also known as:- BSPI
- Bone sialoprotein 1
- BNSP
- early T-lymphocyte activation 1
- Urinary stone protein
- Osteopontin (OPN)
- ETA-1
- SPP1
- Nephropontin
- OPN
- Uropontin
- Osteopontin
- SPP-1
- Secreted phosphoprotein 1
Description…
Osteopontin, also known as SPP1 or OPN, a secreted, integrin-binding matrix phosphorylated glycoprotein is involved in bone remodeling by osteoclasts and is overexpressed in many advanced cancers. Osteopontin has been identified as one of the leading genes that promotes the metastasis of hepatocellular carcinoma.
Datasets
There are no datasets associated with this biomarker.
Attributes
| QA State: | Curated |
|---|---|
| Type: | Proteomic |
| HGNC Name: | SPP1 |
The following organs have data associated with this biomarker…
Attributes
| Phase: | 3 |
|---|---|
| QA State: | Curated |
Organ-specific information for this biomarker is currently being annotated or is "under review".
Logging in may give you privileges to view additional information.
Contact the
Informatics Center
if you believe you should have access to this biomarker.
Attributes
| Phase: | 2 |
|---|---|
| QA State: | Under Review |
Organ-specific information for this biomarker is currently being annotated or is "under review".
Logging in may give you privileges to view additional information.
Contact the
Informatics Center
if you believe you should have access to this biomarker.
Attributes
| Phase: | 1 |
|---|---|
| QA State: | Under Review |
Organ-specific information for this biomarker is currently being annotated or is "under review".
Logging in may give you privileges to view additional information.
Contact the
Informatics Center
if you believe you should have access to this biomarker.
Attributes
| Phase: | 3 |
|---|---|
| QA State: | Under Review |
Organ-specific information for this biomarker is currently being annotated or is "under review".
Logging in may give you privileges to view additional information.
Contact the
Informatics Center
if you believe you should have access to this biomarker.
Attributes
| Phase: | 2 |
|---|---|
| QA State: |
Organ-specific information for this biomarker is currently being annotated or is "under review".
Logging in may give you privileges to view additional information.
Contact the
Informatics Center
if you believe you should have access to this biomarker.
Organ-specific information for this biomarker is currently being annotated or is "under review". Logging in may give you privileges to view additional information. Contact the Informatics Center if you believe you should have access to this biomarker.
- Ovarian cancer biomarker performance in prostate, lung, colorectal, and ovarian cancer screening trial specimens.
- Scale-based normalization of spectral data.
- Chromosomal localization of the human annexin III (ANX3) gene.
- Identification of 14-3-3 theta as an antigen that induces a humoral response in lung cancer.
- An epigenetic marker panel for detection of lung cancer using cell-free serum DNA.
- Association of the 15q25 and 5p15 lung cancer susceptibility regions with gene expression in lung tumor tissue.
- Contributions of proteome profiling to the molecular analysis of cancer.
- Mining gene expression databases for association rules.
- Inactivation of CDK12 Delineates a Distinct Immunogenic Class of Advanced Prostate Cancer.